scispace - formally typeset
J

Jo Vandesompele

Researcher at Ghent University

Publications -  406
Citations -  67052

Jo Vandesompele is an academic researcher from Ghent University. The author has contributed to research in topics: Neuroblastoma & microRNA. The author has an hindex of 88, co-authored 383 publications receiving 59368 citations. Previous affiliations of Jo Vandesompele include Washington University in St. Louis & Ghent University Hospital.

Papers
More filters
Journal ArticleDOI

Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma

TL;DR: It is shown that pharmacological inhibition of cyclin D1 dependent kinases 4/6 with PD 0332991 with palbociclib reduced the growth of neuroblastoma cell lines, induced G1 cell cycle arrest, and inhibited the cyclIn D1-Rb pathway.
Journal ArticleDOI

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma.

TL;DR: It is observed that these p53-regulated miRNAs inhibit the proliferation of neuroblastoma cells to varying degrees, with the most profound growth inhibition recorded for miR-182-5p.
Journal ArticleDOI

Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene.

TL;DR: The lack of imprinting and absence of somatic mutations in DFFB indicate that it is probably not the neuroblastoma tumour suppressor gene, and exhaustive mutation screening of 41 neuroblastomas and other tumours in which a 1p36 tumour suppressing gene is implicated showed no tumour-specific mutations.
Journal ArticleDOI

Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR

TL;DR: The resulting method, called double-mismatch allele-specific qPCR (DMAS-qPCR), was successfully validated using 12 SNPs and 15 clinically relevant somatic mutations on 48 cancer cell lines and is characterized by high analytical sensitivity and specificity.